“…7,10,59 Different proposals have been made to understand the mechanism of Gyrase inhibition but the molecular details are unknown. 7,9,10,59 It should be mentioned that some authors support the idea that metal atoms are involved in the inhibitions mechanism of Gyrase by quinolones. For this reason, quinolones are also known as metallo-antibiotics, 60 and different studies on…”
Section: Inhibition Of Dna Gyrasementioning
confidence: 99%
“…Particularly, if we take into account that the atoms that probably interact with the metal (4-oxo carbonyl and carboxylate oxygen atoms) are the same that have been proposed to interact with DNA gyrase. 7,9 In contrast to this view, other authors have proposed that metal atoms can be involved in the interaction between ciprofloxacin and DNA-gyrase , 7,[18][19][20] which could A c c e p t e d m a n u s c r i p t 29 Zr, 29 Mo, 24 Ag, 30 Cd, 21,26 Pt, 31 U 32 and Eu 33 have been reported, and there is even a review of these metal complexes. 19 As mentioned above, the most common coordination mode of ciprofloxacin is through the oxygen atoms of the 4-oxo carbonyl and the carboxylate groups, forming a chelating ring of six atoms.…”
Section: Introductionmentioning
confidence: 97%
“…It is a synthetic antibiotic belonging to fluoroquinolone group with a broad-spectrum bacteria-localising capability. 7,8 Fluoroquinolones suppress the growth of bacteria by inhibiting the activity of DNA gyrase, an essential bacterial enzyme that relieves strain while double-stranded DNA is being unwound. 7,9,10 Technetium-99m labelled ciprofloxacin ( 99m Tc-ciprofloxacin or Infecton) was first introduced in the 1990s and has been extensively studied as an infection-specific radiopharmaceutical.…”
Section: Introductionmentioning
confidence: 99%
“…7,8 Fluoroquinolones suppress the growth of bacteria by inhibiting the activity of DNA gyrase, an essential bacterial enzyme that relieves strain while double-stranded DNA is being unwound. 7,9,10 Technetium-99m labelled ciprofloxacin ( 99m Tc-ciprofloxacin or Infecton) was first introduced in the 1990s and has been extensively studied as an infection-specific radiopharmaceutical. 5,[11][12][13][14][15][16] However, the global analysis of numerous published studies (including clinical trials) shows contradictory data about the specificity of 99m Tc-ciprofloxacin.…”
“…7,10,59 Different proposals have been made to understand the mechanism of Gyrase inhibition but the molecular details are unknown. 7,9,10,59 It should be mentioned that some authors support the idea that metal atoms are involved in the inhibitions mechanism of Gyrase by quinolones. For this reason, quinolones are also known as metallo-antibiotics, 60 and different studies on…”
Section: Inhibition Of Dna Gyrasementioning
confidence: 99%
“…Particularly, if we take into account that the atoms that probably interact with the metal (4-oxo carbonyl and carboxylate oxygen atoms) are the same that have been proposed to interact with DNA gyrase. 7,9 In contrast to this view, other authors have proposed that metal atoms can be involved in the interaction between ciprofloxacin and DNA-gyrase , 7,[18][19][20] which could A c c e p t e d m a n u s c r i p t 29 Zr, 29 Mo, 24 Ag, 30 Cd, 21,26 Pt, 31 U 32 and Eu 33 have been reported, and there is even a review of these metal complexes. 19 As mentioned above, the most common coordination mode of ciprofloxacin is through the oxygen atoms of the 4-oxo carbonyl and the carboxylate groups, forming a chelating ring of six atoms.…”
Section: Introductionmentioning
confidence: 97%
“…It is a synthetic antibiotic belonging to fluoroquinolone group with a broad-spectrum bacteria-localising capability. 7,8 Fluoroquinolones suppress the growth of bacteria by inhibiting the activity of DNA gyrase, an essential bacterial enzyme that relieves strain while double-stranded DNA is being unwound. 7,9,10 Technetium-99m labelled ciprofloxacin ( 99m Tc-ciprofloxacin or Infecton) was first introduced in the 1990s and has been extensively studied as an infection-specific radiopharmaceutical.…”
Section: Introductionmentioning
confidence: 99%
“…7,8 Fluoroquinolones suppress the growth of bacteria by inhibiting the activity of DNA gyrase, an essential bacterial enzyme that relieves strain while double-stranded DNA is being unwound. 7,9,10 Technetium-99m labelled ciprofloxacin ( 99m Tc-ciprofloxacin or Infecton) was first introduced in the 1990s and has been extensively studied as an infection-specific radiopharmaceutical. 5,[11][12][13][14][15][16] However, the global analysis of numerous published studies (including clinical trials) shows contradictory data about the specificity of 99m Tc-ciprofloxacin.…”
“…54,55 Alguns trabalhos apontam que o íon Mg(II) pode estar envolvido no modo de ação das fluorquinolonas, tendo importante papel na ligação destas substâncias ao complexo DNA-girase. [56][57][58] Porém, há outros que relatam que as fluorquinolonas perderiam atividade no organismo na presença do íon Mg(II), dentre outros. 59,60 Como já mencionado, a coordenação de íons metálicos a molécu-las que por si mesmas apresentam atividade antimicrobiana pode ser utilizada como uma importante estratégia para aumentar sua eficácia, inclusive em cepas resistentes.…”
Section: Coordenação De Metais a Quinolonas E Fluorquinolonasunclassified
Recebido em 12/1/10; aceito em 2/8/10; publicado na web em 16/11/10 COORDINATION OF METALS TO ANTIBIOTICS AS A STRATEGY TO COMBAT BACTERIAL RESISTANCE. Antibiotic resistance has been growing at an alarming rate and consequently the arsenal of effective antibiotics against Gram-negative and Gram-positive bacteria has dropped dramatically. In this sense there is a strong need to produce new substances that not only have good spectrum of activity, but having new mechanisms of action. In this regard, this paper emphasizes the coordination of metals to antibiotics as a strategy for reversing antibiotic resistance and production of new drugs, with a special focus on quinolones, fluoroquinolones, sulfonamides and tetracyclines.Keywords: antibiotics; metal-based drugs; bacterial resistance.
INTRODUÇÃOA descoberta dos antibióticos representa um dos mais importantes marcos da medicina moderna. A introdução das sulfonamidas em 1930 e da penicilina na década posterior provocaram um grande avanço no tratamento de doenças infecciosas, causando uma drásti-ca diminuição nas taxas de mortalidade e uma enorme sensação de bem-estar. 1 O sucesso dos primeiros antibióticos na cura de doenças até então consideradas letais acarretou uma intensa busca por novas drogas. De fato, as décadas de 40, 50 e 60 do século passado foram marcadas pela imensa quantidade de antibióticos produzidos e rapidamente incorporados às práticas clínicas. 2 No entanto, nas décadas posteriores houve um declínio na produção destes compostos. Entre o lançamento das quinolonas em 1962 até a aprovação das oxazolidinonas em 2000, houve pouca inovação no que se refere à introdução de novas classes de antibióticos de uso clínico bem-sucedido. 2 Quando um antibiótico é descoberto e introduzido no mercado, sua utilidade clínica começa a diminuir até um ponto em que há um aumento na restrição de seu uso. Esta restrição é provocada pelo surgimento de cepas resistentes. As bactérias surgiram na terra há bilhões de anos e para sobreviver desenvolveram mecanismos de resistência aos antibióticos que são encontrados livres na natureza. 3 Portanto, não é surpreendente o fato de que muitos antibióticos lançados nas últimas décadas, que são em sua ampla maioria de origem natural ou semissintética, terem utilidade limitada na época de sua descoberta e em pouco tempo se tornarem obsoletos. 3 Outro fator que contribui muito para tornar um antibiótico menos eficiente é a sua utilização indiscriminada e incorreta, o que vem a favorecer o surgimento de micro-organismos resistentes. Atualmente, algumas classes de micro-organismos representam extrema preocupação para a saúde publica. Dentre os que mais provocam mortes no mundo estão o Staphylococcus aureus meticilina-resistente (MRSA), Staphylococcus aureus vancomicina-resistente (VRSA), Escherichia coli, Klebsiella pneumoniae e Pseudomonas aeruginosa, que são bactérias resistentes a múltiplas drogas. Os processos infecciosos causados por estas classes de micro-organismos geralmente estão associados com alta letalidade e altos custos d...
While the treatment of malaria has until recently relied upon a small number of therapeutic agents with a few mechanisms of action, the past decade has seen a huge growth in the number of targets being addressed and new agents being pushed to the clinic. This chapter briefly reviews existing agents and close homologs in development and then carefully explores new targets and new chemotypes being developed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.